查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1543978

全球移植診斷市場

Transplant Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 158 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球移植診斷市場將達到 63 億美元

全球移植診斷市場預計 2023 年為 45 億美元，預計到 2030 年將達到 63 億美元，2023 年至 2030 年複合年成長率為 5.0%。分子檢測技術是本報告分析的細分市場之一，預計複合年成長率為 5.7%，到分析期結束時將達到 40 億美元。分析期間非分子檢測技術領域的複合年成長率預計為4.0%。

美國市場預估12億美元，中國預期複合年成長率8.8%

預計 2023 年美國移植診斷市場規模將達 12 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達15億美元，2023-2030年分析期間複合年成長率為8.8%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 1.8% 和 5.2%。在歐洲，德國的複合年成長率預計為 2.2%。

全球移植診斷市場 - 主要趨勢和促進因素總結

什麼是移植診斷以及為什麼它很重要？

移植診斷是指用於評估和監測器官移植適宜性和健康狀況的醫學檢查和程序。這些診斷包括組織配對、交叉配血和移植後監測以檢測排斥或感染疾病。移植診斷透過識別合適的捐贈者、預防排斥反應和管理受者患者的健康，在確保器官移植成功方面發揮關鍵作用。這些診斷的準確性和可靠性對於改善移植結果和提高患者存活率至關重要。

技術創新如何影響市場？

技術創新極大地推動了移植診斷領域的發展。聚合酵素鏈鎖反應（PCR）和次世代定序（NGS）等分子診斷技術的發展提高了組織配對和交叉配型的準確性和速度。這些技術可以更準確地識別相容的捐贈者並及早發現潛在的排斥反應。生物標記發現的進步導致了監測移植物健康和檢測感染的非侵入性測試的發展。此外，人工智慧（AI）和機器學習演算法的整合增強了資料分析和預測能力，以改善移植患者的管理。這些技術進步正在擴大移植診斷的範圍和有效性，並促進其在臨床實踐中的採用。

主要使用者是誰？

移植診斷的主要使用者包括移植中心、醫院、診斷實驗室和研究機構。移植中心和醫院依靠這些診斷來確保器官移植的適當性和成功，並需要準確、及時的結果來指南臨床決策。診斷實驗室進行各種與移植相關的測試，需要高通量和可靠的診斷工具。研發機構利用移植診斷來研究移植免疫學並開發新的診斷和治療方法，並尋求先進和創新的技術。每個使用者群體都需要提供高精度、可靠性和易用性的移植診斷，以支援器官移植中涉及的複雜且關鍵的過程。

移植診斷市場成長的驅動力是什麼？

移植診斷市場的成長是由多種因素推動的，例如器官移植數量的增加、診斷技術的進步以及慢性病盛行率的上升。由於器官衰竭發生率的增加和移植技術的改進，對器官移植的需求不斷增加，這增加了對準確可靠的移植診斷的需求。分子診斷和生物標記發現等診斷技術的進步正在提高移植診斷的準確性和速度，促進其在臨床實踐中的採用。糖尿病和高血壓等慢性病的流行導致器官衰竭的增加，進一步推動了對移植診斷的需求。此外，政府的措施以及對移植研究和診斷工具開發的資助正在支持市場成長。

受訪企業範例（11家知名企業）

  • Becton, Dickinson and Company
  • Biofortuna Ltd.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • F. Hoffmann-La Roche AG
  • GenDx
  • Hologic, Inc.
  • Illumina, Inc.
  • Immucor, Inc.
  • Luminex Corporation
  • Merck KgaA
  • Omixon
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP15303

Global Transplant Diagnostics Market to Reach US$6.3 Billion by 2030

The global market for Transplant Diagnostics estimated at US$4.5 Billion in the year 2023, is expected to reach US$6.3 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Molecular Assays Technology, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Non-Molecular Assays Technology segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 8.8% CAGR

The Transplant Diagnostics market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Transplant Diagnostics Market - Key Trends & Drivers Summarized

What Are Transplant Diagnostics and Why Are They Critical?

Transplant diagnostics are medical tests and procedures used to evaluate and monitor the compatibility and health of organ transplants. These diagnostics include tissue typing, cross-matching, and post-transplant monitoring to detect rejection and infections. Transplant diagnostics play a crucial role in ensuring the success of organ transplants by identifying suitable donors, preventing rejection, and managing the health of transplant recipients. The accuracy and reliability of these diagnostics are essential for improving transplant outcomes and enhancing patient survival rates.

How Have Technological Innovations Impacted the Market?

Technological innovations have significantly advanced the field of transplant diagnostics. The development of molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), has improved the accuracy and speed of tissue typing and cross-matching. These technologies enable more precise identification of compatible donors and early detection of potential rejection. Advances in biomarker discovery have led to the development of non-invasive tests for monitoring graft health and detecting infections. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms has enhanced data analysis and predictive capabilities, improving the management of transplant patients. These technological advancements have expanded the scope and effectiveness of transplant diagnostics, driving their adoption in clinical practice.

Who Are the Key Users and What Are Their Needs?

The key users of transplant diagnostics include transplant centers, hospitals, diagnostic laboratories, and research institutions. Transplant centers and hospitals rely on these diagnostics to ensure the compatibility and success of organ transplants, requiring accurate and timely results to guide clinical decisions. Diagnostic laboratories perform various transplant-related tests, demanding high-throughput and reliable diagnostic tools. Research institutions utilize transplant diagnostics to study transplant immunology and develop new diagnostic and therapeutic approaches, seeking advanced and innovative technologies. Each user group requires transplant diagnostics that offer high precision, reliability, and ease of use to support the complex and critical processes involved in organ transplantation.

What Is Driving Growth in the Transplant Diagnostics Market?

The growth in the transplant diagnostics market is driven by several factors, including the increasing number of organ transplants, advancements in diagnostic technologies, and the rising prevalence of chronic diseases. The growing demand for organ transplants, driven by the rising incidence of organ failure and improved transplant techniques, has increased the need for accurate and reliable transplant diagnostics. Advancements in diagnostic technologies, such as molecular diagnostics and biomarker discovery, have enhanced the precision and speed of transplant diagnostics, driving their adoption in clinical practice. The rising prevalence of chronic diseases, such as diabetes and hypertension, has led to an increase in organ failures, further fueling the demand for transplant diagnostics. Additionally, government initiatives and funding for transplant research and the development of diagnostic tools have supported market growth.

Select Competitors (Total 11 Featured) -

  • Becton, Dickinson and Company
  • Biofortuna Ltd.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • F. Hoffmann-La Roche AG
  • GenDx
  • Hologic, Inc.
  • Illumina, Inc.
  • Immucor, Inc.
  • Luminex Corporation
  • Merck KgaA
  • Omixon
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transplant Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Organ Failures
    • Advancements in Molecular Diagnostics
    • Growth in Personalized Medicine
    • Development of Non-Invasive Diagnostic Tools
    • Rising Adoption of Genetic Testing
    • Expansion of Organ Transplant Programs
    • Innovations in Biomarker Discovery
    • Increasing Funding for Transplant Research
    • Growth in Point-of-Care Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Molecular Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Non-Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Non-Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Non-Molecular Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Reagent & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Reagent & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Reagent & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Transplant Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • JAPAN
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • CHINA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • EUROPE
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • FRANCE
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • GERMANY
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • INDIA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • AFRICA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030

IV. COMPETITION